2024 Global Infectious Disease Testing Market for 100 Tests: US, Europe, Japan--Supplier Shares and Strategies, Technology and Instrumentation Review, Emerging Opportunities

August 2024 | - | ID: 2619C8ABA147EN
Venture Planning Group

Abstracts

This comprehensive seven-country report contains 1,954 pages, 824 tables, and is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding infectious disease testing market, in evaluating emerging opportunities and developing effective business strategies.The report provides market segmentation analysis of over 100 diseases and viruses in seven countries; assessment of emerging technologies; review of current instrumentation; as well as strategic profiles of leading suppliers and recent market entrants with innovative technologies and products.Infectious Diseases Analyzed in the ReportAIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Carbapenemase, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes, Influenza, Legionella, Lyme Disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, Norovirus, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus, Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.Geographic Coverage%li%France%li%Germany%li%Italy%li%Japan%li%Spain%li%UK%li%USMarket Segmentation Analysis%li%Sales and market shares of major suppliers of infectious disease diagnostic products, by country and individual test.%li%Test and sales forecasts for over 90 infectious disease diagnostic assays by country, individual test and market segment: %li%Hospitals %li%Blood Banks %li%Commercial/Private Laboratories %li%Physician Offices/Group Practices %li%Public Health Laboratories%li%Review of market dynamics, trends, structure, size, growth and major suppliers by country.Current and Emerging Products%li%In-depth examination of over 90 major diseases, including etiology, current diagnostic tests, vaccines, drugs and market needs.%li%Review of major analyzers used for infectious disease testing, including their operating characteristics, features and selling prices.Technology Review%li%Assessment of molecular diagnostic, monoclonal antibody, immunoassay,& and other technologies and their potential applications for infectious disease testing.%li%Extensive listings of companies developing or marketing infectious disease diagnostic products worldwide by individual test.Competitive Assessments%li%Detailed strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.Worldwide Market Overview%li%Estimated universe of laboratories performing infectious disease testing by country.%li%Test volume and sales projections for major infectious disease diagnostic assays by country.Opportunities and Strategic Recommendations%li%Emerging opportunities for new instrumentation, reagents, IT and other products with significant market appeal during the next five years.%li%Design criteria for decentralized testing products.%li%Alternative market penetration strategies.%li%Potential market entry barriers and risks.Contains 1,954 pages and 824 tables

Contents

I. Introduction
II. Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Information Technology
D. Auxiliary Products
III. Design Criteria for Decentralized Testing Products
IV. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
V. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VI. Worldwide Overview of Major Tests,
Technologies, and Instrumentation
A. Major Infectious Disease Tests

1. AIDS: HIV/HIV-1/2/COMBO, HIVAG/HIV NAT,

Western Blot, HTLV-I/II

2. ADENOVIRUS

3. AEROMONAS

4. ANTHRAX/BACILLUS ANTHRACIS

5. ARBOVIRUSES

6. BABESIOSIS

7. BACILLARY EPITHELIOID ANGIOMATOSIS (BEA)

and Other Bartonella (Rochalimaea)

8. BLASTOCYSTIS HOMINIS

9. BRUCELLA

10. CAMPYLOBACTER

11. CANDIDA

Table of Contents (continued)

12. CHAGAS DISEASE

13. CHANCROID

14. CHLAMYDIA

15. CLOSTRIDIUM DIFFICILE

16. CORONAVIRUSES

17. COXSACKIEVIRUSES

18. CREUTZFELDT-JAKOB’S DISEASE

19. CRYPTOSPORIDIUM PARVUM

20. CYCLOSPORA CAYETANENSIS

21. CYTOMEGALOVIRUS

22. EBOLA VIRUS

23. E. COLI

24. ECHOVIRUS

25. ENCEPHALITIS

26. ENTEROVIRUSES

27. EPSTEIN-BARR VIRUS

28. GIARDIA LAMBLIA

29. GONORRHEA

30. GRANULOMA INGUINALE

31. HANTAVIRUS

32. HELICOBACTER PYLORI

33. HEPATITIS: HAV NAT, HBV NAT, HBS AG, HCV, HCV NAT,

Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag,
HBe Ag, ALT/SGPT

34. HERPES SIMPLEX VIRUS

35. HUMAN HERPES VIRUS-6 (HHV-6)

36. INFLUENZA VIRUSES

37. LEGIONELLA

38. LYME DISEASE

39. LYMPHOGRANULOMA VENEREUM (LGV)

40. MALARIA

41. MEASLES (RUBEOLA)

42. MENINGITIS

43. MICROSPORIDIUM

44. MONONUCLEOSIS

45. MUMPS

46. MYCOPLASMA

47. PAPILLOMAVIRUSES

48. PARVOVIRUS B19

49. PNEUMONIA

50. POLYOMAVIRUSES

51. PSEUDOMONAS AERUGINOSA

52. RABIES

53. RESPIRATORY SYNCYTIAL VIRUS (RSV)

54. RHINOVIRUSES

55. ROTAVIRUS